Summarised consolidated statement of cash flows

for the year ended 30 September 2016

Download (EXCEL)


R’m 30 September 
2016 
 
Change 
  30 September 
2015 
 
Cash generated from operations 4 024     4.7     3 842    
Interest received  12           12    
Tax paid  (981)          (903)   
Net cash generated from operating activities  3 055     3.5     2 951    
Capital expenditure  (1 013)          (1 181)   
Investments  (1 068)          (2 037)   
Other  29           –    
Net cash utilised in investing activities¹  (2 052)          (3 218)   
Interest-bearing borrowings raised  1 961           4 268    
Interest-bearing borrowings and preference shares repaid  (1 437)          (1 814)   
Dividends paid  (1 087)          (1 520)   
Other  (1 114)          (712)   
Net cash (utilised in)/generated from financing activities  (1 677)          222    
Net decrease in cash and cash equivalents  (674)          (45)   
Cash and cash equivalents – beginning of the year  255           267    
Cash balances acquired through business combinations  56           20    
Effect of foreign exchange rate movements  (63)          13    
Cash and cash equivalents – end of the year  (426)          255    
1 The cash utilised in investing activities includes the acquisitions in Poland for R748 million, and the additional shares in Max Healthcare Institute Limited, India for
R320 million.